Exostosin-Positive Membranous Nephropathy and Autoimmune Hepatitis: Successful Remission with Immunosuppressive Therapy: A Case Report
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. With the discovery of numerous novel antigens associated with MN, its nomenclature has shifted towards an antigen-based classification. Exostosin-1 (EXT1) and Exostosin-2 (EXT2) are two target antigens associated with autoimmune diseases, especially lupus nephritis. To the best of our knowledge, while MN has been described with autoimmune liver diseases, EXT-positive MN has not been previously described with autoimmune hepatitis (AIH). We report the case of successful remission of EXT-2-positive MN and AIH with steroids, antimetabolite immunosuppressive therapy, and budesonide.
Authors
- Michael Kuperman
- Satyapal Chahar (ORCID: https://orcid.org/0000-0002-0888-5347)
- Bushra Syed
- Mohammad Atari
- Tiffany Caza
- Pradeep Vaitla (ORCID: https://orcid.org/0000-0001-5234-6722)
- Mohammed Hassanein (ORCID: https://orcid.org/0000-0002-3540-0595)
- RobertM. Evans
Institutions
- Jackson Memorial Hospital (US)
- University of Mississippi Medical Center (US)
- Arkana Laboratories (US)
- Colorado Kidney Care (US)
Publication Details
- Journal
- Indian Journal of Nephrology
- Published
- 2025-11-08
- DOI
- https://doi.org/10.25259/ijn_143_2025
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00